Ngā hua rapu

Ngā kaupapa kua whakahuatia i roto i tō rapu.
Whakamahine hua
  1. 1
    Multicolor-FICTION

    Multicolor-FICTION mā José I. Martı́n-Subero, Ilse Chudoba, Lana Harder, Stefan Gesk, W. Grote, Francisco J. Novo, Marı́a José Calasanz, Reiner Siebert

    I whakaputaina 2002
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  2. 2
    Phase 2 trial of combined cisplatin, etoposide, gemcitabine, and methylprednisolone (PEGS) in peripheral T‐cell non‐Hodgkin lymphoma

    Phase 2 trial of combined cisplatin, etoposide, gemcitabine, and methylprednisolone (PEGS) in peripheral T‐cell non‐Hodgkin lymphoma mā Daruka Mahadevan, Joseph M. Unger, Catherine Spier, Daniel O. Persky, Fay Young, Michael LeBlanc, Richard I. Fisher, Thomas P. Miller

    I whakaputaina 2012
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  3. 3
    Enhanced Antitumorigenic Effects in Glioblastoma on Double Targeting of Pleiotrophin and Its Receptor ALK

    Enhanced Antitumorigenic Effects in Glioblastoma on Double Targeting of Pleiotrophin and Its Receptor ALK mā Marius Grzelinski, Florian Steinberg, Tobias Martens, Frank Czubayko, Katrin Lamszus, Achim Aigner

    I whakaputaina 2009
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  4. 4
    Primary Anaplastic Large-Cell Lymphoma in Adults: Clinical Presentation, Immunophenotype, and Outcome

    Primary Anaplastic Large-Cell Lymphoma in Adults: Clinical Presentation, Immunophenotype, and Outcome mā Hervé Tilly, Philippe Gaulard, Éric Lepage, Charles Dumontet, J Diébold, Isabelle Plantier, Françoise Berger, Michel Symann, Tony Petrella, P Lederlin, Josette Brière

    I whakaputaina 1997
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  5. 5
    A novel <i>KIF5B‐ALK</i> variant in nonsmall cell lung cancer

    A novel <i>KIF5B‐ALK</i> variant in nonsmall cell lung cancer mā Daisy Wing‐Sze Wong, Elaine Lai‐Han Leung, Sunny Kit‐Man Wong, Vicky Pui‐Chi Tin, Alan Dart‐Loon Sihoe, Lik‐Cheung Cheng, Joseph S. K. Au, Lap‐Ping Chung, Maria Pik Wong

    I whakaputaina 2011
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  6. 6
    A New Subtype of Large B-Cell Lymphoma Expressing the ALK Kinase and Lacking the 2; 5 Translocation

    A New Subtype of Large B-Cell Lymphoma Expressing the ALK Kinase and Lacking the 2; 5 Translocation mā Georges Delsol, Laurence Lamant, Bernard Mariamé, Karen Pulford, Nicole Dastugue, Pierre Brousset, Françoise Rigal‐Huguet, Talal Al Saati, Douglas Pat Cerretti, Stephan W. Morris, David Y. Mason

    I whakaputaina 1997
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  7. 7
    PF-06463922, an ALK/ROS1 Inhibitor, Overcomes Resistance to First and Second Generation ALK Inhibitors in Preclinical Models

    PF-06463922, an ALK/ROS1 Inhibitor, Overcomes Resistance to First and Second Generation ALK Inhibitors in Preclinical Models mā Helen Y. Zou, Luc Friboulet, David P. Kodack, Lars D. Engstrom, Qiuhua Li, Melissa West, Ruth W. Tang, Hui Wang, Konstantinos Tsaparikos, Jinwei Wang, Sergei Timofeevski, Ryohei Katayama, Dac M. Dinh, Hieu Lam, Justine L. Lam, Shinji Yamazaki, Wenyue Hu, Bhushankumar Patel, Divya Bezwada, Rosa L. Frias, Eugene Lifshits, Sidra Mahmood, Justin F. Gainor, Timothy Affolter, Patrick B. Lappin, Hovhannes J. Gukasyan, Nathan Lee, Shibing Deng, Rakesh K. Jain, Ted W. Johnson, Alice T. Shaw, Valeria R. Fantin, Tod Smeal

    I whakaputaina 2015
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  8. 8
    Rapid‐onset hypogonadism secondary to crizotinib use in men with metastatic nonsmall cell lung cancer

    Rapid‐onset hypogonadism secondary to crizotinib use in men with metastatic nonsmall cell lung cancer mā Andrew Weickhardt, Micol S. Rothman, Smita Salian‐Mehta, Katja Kiseljak‐Vassiliades, Ana B. Oton, Robert C. Doebele, Margaret E. Wierman, D. Ross Camidge

    I whakaputaina 2012
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  9. 9
    Heart rate decrease during crizotinib treatment and potential correlation to clinical response

    Heart rate decrease during crizotinib treatment and potential correlation to clinical response mā Sai‐Hong Ignatius Ou, Wilson P. Tong, Michele C. Azada, Christina T. Siwak-Tapp, Joni Dy, Jonathan A. Stiber

    I whakaputaina 2013
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  10. 10
    Retrovirus-Mediated Gene Transfer of NPM-ALK Causes Lymphoid Malignancy in Mice

    Retrovirus-Mediated Gene Transfer of NPM-ALK Causes Lymphoid Malignancy in Mice mā Martin U. Kuefer, A. Thomas Look, Karen Pulford, Frederick G. Behm, Paul K. Pattengale, David Y. Mason, Stephan W. Morris

    I whakaputaina 1997
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  11. 11
    The use of stained cytologic direct smears for <i>ALK</i> gene rearrangement analysis of lung adenocarcinoma

    The use of stained cytologic direct smears for <i>ALK</i> gene rearrangement analysis of lung adenocarcinoma mā Bryan L. Betz, Catherine A. Dixon, Helmut C. Weigelin, Stewart M. Knoepp, Michael H. Roh

    I whakaputaina 2013
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  12. 12
    ALK‐positive non–small cell lung cancer: Mechanisms of resistance and emerging treatment options

    ALK‐positive non–small cell lung cancer: Mechanisms of resistance and emerging treatment options mā Conor Steuer, Suresh S. Ramalingam

    I whakaputaina 2014
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  13. 13
    Identification of Driving ALK Fusion Genes and Genomic Landscape of Medullary Thyroid Cancer

    Identification of Driving ALK Fusion Genes and Genomic Landscape of Medullary Thyroid Cancer mā Jun Ho Ji, Young Lyun Oh, Min Eui Hong, Jae Won Yun, Hyunwoo Lee, Kim DeokGeun, Yongick Ji, Kim Duk-Hwan, Woong‐Yang Park, Hyun‐Tae Shin, Kyoung‐Mee Kim, Myung‐Ju Ahn, Keunchil Park, Jong‐Mu Sun

    I whakaputaina 2015
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  14. 14
    Identification of anaplastic lymphoma kinase fusions in renal cancer

    Identification of anaplastic lymphoma kinase fusions in renal cancer mā Emiko Sugawara, Yuki Togashi, Naoto Kuroda, Seiji Sakata, Satoko Hatano, Reimi Asaka, Takeshi Yuasa, Junji Yonese, Masanobu Kitagawa, Hiroyuki Mano, Yuichi Ishikawa, Kengo Takeuchi

    I whakaputaina 2012
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  15. 15
    Detection of Anaplastic Lymphoma Kinase (ALK) and Nucleolar Protein Nucleophosmin (NPM)-ALK Proteins in Normal and Neoplastic Cells With the Monoclonal Antibody ALK1

    Detection of Anaplastic Lymphoma Kinase (ALK) and Nucleolar Protein Nucleophosmin (NPM)-ALK Proteins in Normal and Neoplastic Cells With the Monoclonal Antibody ALK1 mā Karen Pulford, Laurence Lamant, Stephan W. Morris, Lisa H. Butler, Katrina Wood, David A. Stroud, Georges Delsol, David Y. Mason

    I whakaputaina 1997
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  16. 16
    Updated Evidence on the Mechanisms of Resistance to ALK Inhibitors and Strategies to Overcome Such Resistance: Clinical and Preclinical Data

    Updated Evidence on the Mechanisms of Resistance to ALK Inhibitors and Strategies to Overcome Such Resistance: Clinical and Preclinical Data mā Gouji Toyokawa, Takashi Seto

    I whakaputaina 2015
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  17. 17
    ALK-rearrangements and testing methods in non-small cell lung cancer: a review

    ALK-rearrangements and testing methods in non-small cell lung cancer: a review mā Rodney E. Shackelford, Moiz Vora, Kim Mayhall, James D. Cotelingam

    I whakaputaina 2014
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  18. 18
    Amplification of genomic DNA demonstrates the presence of the t(2;5) (p23;q35) in anaplastic large cell lymphoma, but not in other non- Hodgkin's lymphomas, Hodgkin's disease, or lymphomatoid papulosis

    Amplification of genomic DNA demonstrates the presence of the t(2;5) (p23;q35) in anaplastic large cell lymphoma, but not in other non- Hodgkin's lymphomas, Hodgkin's disease, or l... mā AH Sarris, R. Luthra, V. Papadimitracopoulou, M. Waasdorp, Meletios Α. Dimopoulos, J. A. McBride, Fernando Cabanillas, Madeleine Duvic, AB Deisseroth, SW Morris, WC Pugh

    I whakaputaina 1996
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  19. 19
    Diagnostic assays for identification of anaplastic lymphoma kinase‐positive non–small cell lung cancer

    Diagnostic assays for identification of anaplastic lymphoma kinase‐positive non–small cell lung cancer mā Andrew Weickhardt, Dara L. Aisner, Wilbur A. Franklin, Marileila Varella‐Garcia, Robert C. Doebele, D. Ross Camidge

    I whakaputaina 2012
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  20. 20
    STUMP un“stumped”: anti-tumor response to anaplastic lymphoma kinase (ALK) inhibitor based targeted therapy in uterine inflammatory myofibroblastic tumor with myxoid features harboring DCTN1-ALK fusion

    STUMP un“stumped”: anti-tumor response to anaplastic lymphoma kinase (ALK) inhibitor based targeted therapy in uterine inflammatory myofibroblastic tumor with myxoid features harbo... mā Vivek Subbiah, Caitlin McMahon, Shreyaskumar Patel, Ralph Zinner, Elvio G. Silva, Julia A. Elvin, Ishwaria M. Subbiah, Chimela Ohaji, Dhakshina Moorthy Ganeshan, Deepa Anand, Charles F. Levenback, Jenny Berry, Timothy J. Brennan, Juliann Chmielecki, Zachary R. Chalmers, John D. Mayfield, Vincent A. Miller, Philip J. Stephens, Jeffrey S. Ross, Siraj M. Ali

    I whakaputaina 2015
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:

Ngā utauta rapu: